• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[伐尼克兰——吸烟者的新希望?]

[Varenicline--a new chance for smokers?].

作者信息

Goniewicz Maciej Lukasz, Koszowski Bartosz, Czogała Jan, Sobczak Andrzej

机构信息

Zakład Chemii Ogólnej i Nieorganicznej, Katedry Chemii Ogólnej i Analitycznej, Slaskiego Uniwersytetu Medycznego w Katowicach.

出版信息

Przegl Lek. 2007;64(10):899-902.

PMID:18409337
Abstract

Cigarette smokers believe that quitting smoking is the hardest thing in their life. Modern pharmacology offers a wide range of various drugs and therapies that might support smoking cessation. One of the most effective drug is varenicline. Varenicline has been introduced this year to Polish pharmaceutical market by Pfizer company under the trade name Champix. The aim of the study was to critically review all new information about Champix pharmacology and pharmacokinetics but also evaluate safety and economical aspects of using this new drug. From the presented data it might be concluded that nowadays varenicline is the most effective drug used in smoking cessation (about 40%). The unique properties of varenicline, which is a partial agonist and antagonist to alpha4beta2 nicotinic receptor, are the reasons of dual mechanism of the drug action. The agonist effect is caused by binding to nicotinic receptors and stimulating receptor-mediated activity. The antagonist effect occurs when varenicline blocks the ability of nicotine to activate nicotinic receptors. The most frequently adverse effects of varenicline are: nausea, headache, insomnia, and abnormal dreams. Although the price of complete therapy with Champix seems to be quite high, but potential benefits (in case of therapy finished successfully) are much higher than these costs. Pharmacological properties of varenicline described in the article, along with its high relative effectiveness and safeness, make the drug very attractive and promising for the smokers who want to quit.

摘要

吸烟者认为戒烟是他们生活中最困难的事情。现代药理学提供了各种各样的药物和疗法来辅助戒烟。最有效的药物之一是伐尼克兰。今年,辉瑞公司以畅沛(Champix)为商品名将伐尼克兰引入波兰药品市场。本研究的目的是严格审查关于畅沛药理学和药代动力学的所有新信息,同时评估使用这种新药的安全性和经济性。从所呈现的数据可以得出结论,如今伐尼克兰是用于戒烟最有效的药物(成功率约为40%)。伐尼克兰作为α4β2烟碱受体的部分激动剂和拮抗剂所具有的独特性质,是其双重作用机制的原因。激动剂效应是通过与烟碱受体结合并刺激受体介导的活性而产生的。当伐尼克兰阻断尼古丁激活烟碱受体的能力时,就会产生拮抗剂效应。伐尼克兰最常见的不良反应有:恶心、头痛、失眠和异常梦境。虽然使用畅沛进行完整治疗的价格似乎相当高,但潜在益处(如果治疗成功完成)远高于这些成本。本文中描述的伐尼克兰的药理学特性,以及其较高的相对有效性和安全性,使得该药物对想要戒烟的吸烟者非常有吸引力且前景广阔。

相似文献

1
[Varenicline--a new chance for smokers?].[伐尼克兰——吸烟者的新希望?]
Przegl Lek. 2007;64(10):899-902.
2
Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.伐尼克兰:一种被批准用于戒烟的选择性α4β2烟碱型乙酰胆碱受体部分激动剂。
Cardiol Rev. 2007 May-Jun;15(3):154-61. doi: 10.1097/01.crd.0000260270.12829.45.
3
Smoking cessation: an overview of treatment options with a focus on varenicline.戒烟:以伐尼克兰为重点的治疗选择概述
Pharmacotherapy. 2007 Nov;27(11):1550-7. doi: 10.1592/phco.27.11.1550.
4
Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.菲律宾吸烟者使用伐伦克林戒烟的安全性和有效性观察性研究。
Curr Med Res Opin. 2011 Oct;27(10):1869-75. doi: 10.1185/03007995.2011.607436. Epub 2011 Aug 12.
5
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.α4β2烟碱型乙酰胆碱受体部分激动剂伐尼克兰的药理学特性,一种有效的戒烟辅助药物。
Neuropharmacology. 2007 Mar;52(3):985-94. doi: 10.1016/j.neuropharm.2006.10.016. Epub 2006 Dec 8.
6
[New drugs; varenicline].[新药;伐尼克兰]
Ned Tijdschr Geneeskd. 2007 Nov 10;151(45):2503-4.
7
Varenicline in smoking cessation.伐伦克林戒烟。
Expert Rev Respir Med. 2010 Jun;4(3):291-9. doi: 10.1586/ers.10.27.
8
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.新型选择性烟碱型乙酰胆碱受体部分激动剂伐尼克兰用于戒烟的疗效和安全性。
Arch Intern Med. 2006;166(15):1571-7. doi: 10.1001/archinte.166.15.1571.
9
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.伐尼克兰(一种选择性烟碱受体部分激动剂)在健康吸烟者和非吸烟者中的单剂量药代动力学。
J Clin Pharmacol. 2006 Sep;46(9):991-8. doi: 10.1177/0091270006290669.
10
The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.尼古丁依赖部分激动剂治疗的神经生物学基础:伐尼克兰
Int J Clin Pract. 2006 May;60(5):571-6. doi: 10.1111/j.1368-5031.2006.00955.x.